Showing results (241-250 of 261) with videos related to

Sort By:
Pageof 27
JAMA Oncology|May 31, 2026
Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM StudyYiwey Shieh, Rachel S Heise, Lisa Madlensky, et al.
Deutsche Medizinische Wochenschrift (1946)|September 24, 2010
[Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010]H A Ghofrani, O Distler, F Gerhardt, et al.
NPJ Precision Oncology|May 15, 2023
Development and testing of a polygenic risk score for breast cancer aggressivenessYiwey Shieh, Jacquelyn Roger, Christina Yau, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032Stefano Testa, Jonathon E Himes, Ajay Subramanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2022
Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102Caitlyn B Brashears, Bethany C Prudner, Richa Rathore, et al.
Genome Medicine|August 28, 2025
Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trialKirkpatrick B Fergus, Rachel S Heise, Lisa Madlensky, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Chronic thromboembolic pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016]H Wilkens, S Konstantinides, I Lang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)AeRang Kim, Karla V Ballman, Pamela L Wolters, et al.
Nature Communications|August 23, 2017
Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometryBen C Collins, Christie L Hunter, Yansheng Liu, et al.
Nature Communications|March 21, 2024
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancerAshenafi Bulle, Peng Liu, Kuljeet Seehra, et al.
Pageof 27